TITLE

Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study

AUTHOR(S)
Wright, M.; Goldin, R.; Fabre, A.; Lloyd, J.; Thomas, H.; Trepo, C.; Pradat, P.; Thursz, M.
PUB. DATE
April 2003
SOURCE
Gut;Apr2003, Vol. 52 Issue 4, p574
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Introduction: The rate of development of liver fibrosis in hepatitis C virus (HCV) infection varies between individuals. This accounts for the variation in duration of progression to cirrhosis. The aims of this study were: (1) to determine whether fibrosis progresses linearly through the grading scales and (2) to identify factors which influence the rate of fibrosis. Methods: HCV infected patients who had undergone at least one liver biopsy were identified. Biopsies were scored using the modified HAl (Ishak) and METAVIR systems, which were compared. Patients were treatment naïve at first biopsy. Demographic features were examined for their relationship to fibrosis rate (defined as fibrosis stage/infection duration) using univariate and multivariate analysis. A subgroup of patients with two biopsies was examined to test the assumption that fibrosis progresses in a linear fashion. Results: A total of 917 patients were included. Male sex (p<0.O0001), older age at infection (p≤0.00001), and viral genotype non-1 (p=0.005) were ali associated with a rapid rate of fibrosis. On multiple linear regression they accounted for 29.5% of the variability in fibrosis rate (r²=0.295). METAVIR and Ishak scores were highly correlated (r=0.935, p<0.0001). In 137 patients who had two biopsies, the predicted probability for an increase of 1 on the fibrosis score was too Iow to assess linearity. Conclusions: Demographic features account for a minority of fibrosis rate variability. The Ishak and METAVIR scoring systems are equivalent. Linearity of fibrosis progression cannot be assessed in biopsies only a few years apart.
ACCESSION #
9704756

 

Related Articles

  • Progress against hepatitis C infection.  // Patient Care;2/15/2002, Vol. 36 Issue 3, p11 

    Describes the progress of therapy against hepatitis C infection as of February 15, 2002. Most common method of detecting hepatitis C virus (HCV) infection; Primary aim for treating HCV infection; Risk factors for HCV infection.

  • Liver Disease in Persons with Asymptomatic Hepatitis C Virus Infection.  // Annals of Internal Medicine;12/17/2002, Vol. 137 Issue 12, pI-36 

    Summarizes the article 'Prevalence of Liver Disease in a Population of Asymptomatic Persons with Hepatitis C Virus Infection,' published in the December 17, 2002 issue of 'Annals of Internal Medicine.' Aim of finding out how often persons with hepatitis virus C infection but no symptoms have...

  • Prevalence of Liver Disease in a Population of Asymptomatic Persons with Hepatitis C Virus Infection. Alberti, Alfredo; Noventa, Franco; Benvegnù, Luisa; Boccato, Silvia; Gatta, Angelo // Annals of Internal Medicine;12/17/2002, Vol. 137 Issue 12, p951 

    Background: The prevalence of significant liver disease in persons with asymptomatic hepatitis C virus (HCV) infection is unclear. Objective: To determine the prevalence and severity of HCV infection in asymptomatic persons. Design: Population-based cross-sectional study. Setting:...

  • Hepatitis C.  // Hepatitis C (National Institute of Allergy/Infectious Disease);2009, p3 

    The article offers information on hepatitis C, which is an infectious disease of the liver.

  • Do you have hepatitis C? Hager, Mary; Reibstein, Larry // Newsweek;5/4/1998, Vol. 131 Issue 18, p83 

    Focuses on incidence in the United States of the viral infection hepatitis C. Estimated number of Americans who have the disease; Identification of groups at risk for the infection; Diagnosis of the disease; Treatment; Living with the disease.

  • UNDERSTANDING HEPATITIS C. Everson, Gregory T. // Share Guide;Sep/Oct2002, Issue 63, p42 

    Provides information about hepatitis C, a liver disease. Epidemiology; Causes, symptoms and treatment; Tests for hepatitis C.

  • Appendix 3: Hepatitis C search strategy.  // Kidney International Supplement;Apr2008, Issue 109, pS80 

    A variety of information related to Hepatitis C search strategy that relate to articles that appeared in this issue of the periodical "Kidney International" are presented.

  • Hepatitis C What Sisters Need to Know. Wald, Robin // Heart & Soul;Jun/Jul2000, Vol. 7 Issue 3, p80 

    Presents facts about hepatitis C prevention, diagnosis, and treatment.

  • Killer C. Atkinson, Jim // Texas Monthly;Dec98, Vol. 26 Issue 12, p62 

    Explores the etiology of hepatitis C, a disease that infects and destroys liver cells. Experience shared by Doug Bedell, a friend of the author; Drug for the disease developed by Schering-Plough; Detection of the disease; Actions taken by health officials in the United States in connection with...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics